3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
194
Sarcoma
24
Gastrointestinal
22
Lymphoid
18
Genitourinary
18
Myeloid
13
Dermatologic
9
Thoracic
8
Head & Neck
8
Other hematologic neoplasm
6
Endocrine
5
Breast
4
NET
2
Gynecologic
2
Plasma cell
1
Other solid neoplasm
1
Conditions
Neuroendocrine Tumors
69
Gastro-enteropancreatic neuroendocrine tumor
8
Pheochromocytoma
7
Carcinoma, Neuroendocrine
7
Carcinoid Tumor
7
Adenoma, Islet Cell
7
Paraganglioma
6
Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Thyroid Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Carcinoma
4
Serotonin Syndrome
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Mesothelioma
3
Meningioma
3
Liver Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Merkel Cell
3
Carcinoma, Hepatocellular
3
Anus Neoplasms
3
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Glioma
×
NET
×
90 days
×
Clear all
NCT06607692
2026-04-14
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled
NCT05500391
2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2
Recruiting
88 enrolled